It is self-evident that trust arrives on foot and departs on a racehorse. But once earned in the commercial sector, trust goes a long way to ensuring and enhancing the types reputations on which businesses are built. That applies at least as much to the medtech sector as to other businesses, and it could play a significant role in future UK medtech regulation, according to the Association of British HealthTech Industries (ABHI).
The UK medtech sector is at a crossroads in how products will be regulated after the UK parts company with the EU27, in principle at the end of 2020. That...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?